Olmesartan Medications

Olmesartan is an angiotensin receptor blocker employed to treat hypertension by blocking the action of angiotensin II on blood vessels.

Benicar

Olmesartan

$0.67 per pill

10 | 20 | 40mg

Select pack

Olmesartan Information

Olmesartan, an angiotensin II receptor blocker (ARB), is prescribed primarily to lower high blood pressure. By selectively inhibiting the AT₁ receptor, it prevents vasoconstriction and aldosterone release, leading to relaxed blood vessels and reduced fluid retention. The drug is available worldwide under brand names such as Benicar and Olmetec, as well as in generic form marketed through our online pharmacy. While its main indication is hypertension, clinicians sometimes consider it for kidney protection in diabetic patients, although such uses are not formally approved. Understanding how olmesartan works, its dosing options, and safety profile helps patients make informed decisions about their treatment.

What is Olmesartan?

Olmesartan belongs to the class of angiotensin II receptor blockers, a group of medicines that target the renin-angiotensin-aldosterone system (RAAS). The Singapore Health Sciences Authority (HSA) approved olmesartan in 2004 for the treatment of essential hypertension, and the U.S. Food and Drug Administration (FDA) followed with approval in 2002. Since then, regulatory agencies in Europe and Asia have expanded its label to include hypertension in patients with chronic kidney disease. At the molecular level, olmesartan medoxomil-its pro-drug form-converts to active olmesartan, which binds with high affinity to the AT₁ receptor on vascular smooth-muscle cells. Blocking this receptor stops angiotensin II from triggering vasoconstriction, sodium retention, and sympathetic activation. The net effect is a decrease in systemic vascular resistance and modest reduction in plasma volume, translating into lower blood pressure. Both branded tablets (e.g., Benicar 20 mg) and generic versions are stocked through our pharmacy service, providing an affordable option for patients who need consistent blood-pressure control.

How Olmesartan Works

Mechanism of Action

Olmesartan selectively antagonizes the angiotensin II type 1 (AT₁) receptor. By preventing angiotensin II from binding, it inhibits the downstream cascade that normally increases intracellular calcium, leading to vascular smooth-muscle contraction. The drug also reduces aldosterone secretion, limiting sodium and water reabsorption in the distal nephron.

Therapeutic Effects

The blockade of AT₁ receptors produces three key clinical outcomes:

Vasodilation - blood vessels relax, lowering peripheral resistance.
Diuresis - reduced aldosterone limits sodium retention, modestly decreasing fluid volume.
Renal Protection - attenuated intraglomerular pressure can slow progression of hypertensive kidney injury.

Onset and Duration

Peak plasma concentrations are reached 1-2 hours after oral intake, and blood-pressure reductions become evident within 2 weeks of daily dosing. The antihypertensive effect persists for at least 24 hours, allowing once-daily administration. Long-term studies show sustained blood-pressure control over years of continuous use.

Approved Uses and Applications

Approved Indications

Essential Hypertension - confirmed by the HSA, FDA, and EMA as first-line therapy for adults.
Hypertension in Chronic Kidney Disease - approved in several jurisdictions for patients with reduced renal function, where ARBs help preserve glomerular filtration.

Off-Label Uses

Clinicians occasionally prescribe olmesartan for:

Diabetic nephropathy - to reduce albuminuria, though the indication remains off-label.
Heart failure with preserved ejection fraction - some trials suggest modest benefits, but official approval is absent.

Clinical Efficacy

A pooled analysis of three phase III trials published in The New England Journal of Medicine reported a mean systolic blood-pressure reduction of 12 mm Hg and diastolic reduction of 7 mm Hg after 8 weeks of therapy. In patients with stage 3 chronic kidney disease, a Lancet study showed a 25 % decrease in albuminuria after 12 months of olmesartan treatment.

Buying Olmesartan from Our Online Pharmacy

Why Choose Our Service

Patients in Singapore often face supply constraints or higher out-of-pocket costs at brick-and-mortar pharmacies. Through our platform, you can obtain olmesartan discreetly, with transparent pricing and secure delivery.

Brand Names and Generic Options

Benicar - 20 mg and 40 mg tablets, a widely recognized brand.
Olmetec - 10 mg, 20 mg, and 40 mg capsules marketed locally.
Generic Olmesartan Medoxomil - same strengths, typically 30 %-40 % cheaper than branded counterparts.

Quality & Safety

We partner with licensed international pharmacies that comply with WHO Good Manufacturing Practices, ensuring each batch meets strict potency and purity standards.

Pricing & Access

Generic formulations start at SGD .85 per 20 mg tablet, while branded Benicar may cost up to SGD 2.20. All repeat orders qualify for a Lifetime 10 % discount, helping you maintain long-term therapy without financial strain.

Discreet Delivery

Express shipping arrives within ~7 days; standard shipping takes ~3 weeks. Packages are unmarked and encased in protective padding, preserving privacy and product integrity.

Dosing, Formulations & Administration

Available Formulations

Olmesartan is supplied as oral tablets (10 mg, 20 mg, 40 mg) and as capsules in some markets. The pro-drug medoxomil form is built into each dosage unit.

Typical Dosing Ranges

For adults with hypertension, clinicians often initiate therapy at 20 mg once daily, adjusting upward to 40 mg based on blood-pressure response and tolerability. In patients with chronic kidney disease, the same range applies, but clinicians may monitor renal function more closely.

Administration Guidelines

Timing - take the tablet with or without food; consistency helps maintain stable plasma levels.
Food Interactions - high-fat meals do not significantly alter absorption, but grapefruit juice may modestly increase plasma concentration.
Combination Therapy - olmesartan can be combined with diuretics or calcium-channel blockers for synergistic blood-pressure control.

Only a qualified healthcare provider can determine the exact dose for your individual situation.

Safety Profile & Considerations

Common Side Effects

Dizziness - reported in 12 % of patients during the first weeks of therapy.
Headache - observed in 8 % of trial participants.
Abdominal pain - occurs in 6 % of users.
Back pain - noted in 5 % of cases.

Serious Adverse Events

Angioedema - rare but potentially life-threatening; immediate medical attention required.
Acute renal failure - may develop in patients with bilateral renal artery stenosis or severe dehydration.
Hyperkalemia - especially when combined with potassium-sparing diuretics or supplements.

Contraindications

Pregnancy - ARBs are teratogenic; discontinue before conception and during gestation.
Bilateral renal artery stenosis - risk of renal insufficiency.
Known hypersensitivity to olmesartan or any excipients.

Drug Interactions

Other RAAS inhibitors (e.g., ACE inhibitors, other ARBs) - increase risk of hypotension and renal impairment.
Potassium-sparing diuretics (spironolactone, amiloride) - may elevate serum potassium.
Non-steroidal anti-inflammatory drugs (NSAIDs) - can blunt antihypertensive effect and worsen renal function.

Special Populations

Pregnancy & Breastfeeding - contraindicated; minimal excretion into breast milk but safety not established.
Elderly - pharmacokinetics unchanged, yet clinicians monitor for orthostatic hypotension.
Renal Impairment - no dose adjustment needed for mild-to-moderate dysfunction, but renal function should be checked regularly.
Hepatic Impairment - no dose change required, though caution is advised in severe liver disease.

Frequently Asked Questions

How does Olmesartan differ from Losartan? Olmesartan offers a higher binding affinity for the AT₁ receptor, which can translate into a slightly greater blood-pressure reduction at comparable doses. Losartan is a partial antagonist, whereas olmesartan is a full blocker.
How long before Olmesartan produces noticeable effects for hypertension? Most patients experience a reduction in systolic blood pressure within 2 weeks, with the full effect generally plateauing after 4-6 weeks of consistent daily dosing.
What should I do if I experience dizziness after starting Olmesartan? Dizziness is common during the initial titration phase. Rise slowly from sitting or lying positions, stay hydrated, and report persistent symptoms to your clinician, who may adjust the dose or timing.
Is it safe to take Olmesartan with a high-potassium diet? Because olmesartan can increase serum potassium, consuming large amounts of potassium-rich foods (e.g., bananas, oranges) should be discussed with your healthcare provider, especially if you are also on potassium-sparing medications.
Does taking Olmesartan with food affect its absorption? Food does not significantly impact olmesartan’s bioavailability. You may take the tablet with or without meals, but maintaining the same routine each day promotes stable drug levels.
Can Olmesartan be used in patients with diabetes? While not formally approved for diabetic nephropathy, many clinicians prescribe olmesartan to help reduce albuminuria in diabetic patients with hypertension, based on evidence of renal protection.
Are there any over-the-counter supplements that interact with Olmesartan? Herbal products such as St. John’s wort and potassium-containing laxatives may increase the risk of hyperkalemia or blood-pressure fluctuations; disclose all supplement use to your provider.
What monitoring is required while on Olmesartan? Routine checks include blood-pressure measurement, serum electrolytes (especially potassium), and renal function tests every 4-8 weeks after initiation, then periodically thereafter.
Will Olmesartan help with heart-failure symptoms? Some studies suggest modest benefit in heart failure with preserved ejection fraction, but the drug lacks official approval for this indication. Discuss alternative, evidence-based heart-failure therapies with your cardiologist.
What information should I provide my doctor when discussing Olmesartan?
- Complete medical history, including any prior kidney or liver disease.
- Full list of current medications and supplements, highlighting potassium-containing products.
- Recent blood-pressure readings and any symptoms such as dizziness or swelling.
- Pregnancy status or plans, if applicable.

Disclaimer

The information provided about Olmesartan is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing Olmesartan for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing Olmesartan.